Interferon Receptor Signaling Pathways Regulating PD-L1 and PD-L2 Expression

• Distinct changes in plasma protein profiles of cancer patients receiving immune checkpoint inhibitors versus chemotherapy: implications for thrombosis risk and adverse outcomes

  2026 Research and Practice in Thrombosis and Haemostasis article Medicine Cancer Immunotherapy and Biomarkers Open access

  0

  citations
• Regulation of immune checkpoint molecules in cancer immune evasion and therapy

  2026 Nature reviews. Cancer review Medicine Cancer Immunotherapy and Biomarkers

  4

  citations
• Multimodal analysis unveils tumor microenvironment heterogeneity linked to immune activity and evasion

  2024 iScience article Medicine Cancer Immunotherapy and Biomarkers Open access

  16

  citations
• Immunotherapy-activated T cells recruit and skew late-stage activated M1-like macrophages that are critical for therapeutic efficacy

  2024 Cancer Cell article Immunology and Microbiology Immune cells in cancer Open access cited by 1 patent

  163

  citations
• Multimodal analysis unveils tumor microenvironment heterogeneity linked to immune activity and evasion

  2023 bioRxiv (Cold Spring Harbor Laboratory) preprint Medicine Cancer Immunotherapy and Biomarkers Open access

  0

  citations
• Acidosis-mediated increase in IFN-γ-induced PD-L1 expression on cancer cells as an immune escape mechanism in solid tumors

  2023 Molecular Cancer article Medicine Cancer Immunotherapy and Biomarkers Open access cited by 1 patent

  88

  citations
• Personalizing neoadjuvant immune-checkpoint inhibition in patients with melanoma

  2023 Nature Reviews Clinical Oncology review Medicine Cutaneous Melanoma Detection and Management

  50

  citations
• Acidosis-mediated increase in IFN-γ-induced PD-L1 expression on cancer cells as an immune escape mechanism in solid tumors

  2023 Research Square preprint Medicine Cancer Immunotherapy and Biomarkers Open access

  1

  citations
• Mathematical modeling identifies LAG3 and HAVCR2 as biomarkers of T cell exhaustion in melanoma

  2023 iScience article Medicine Cancer Immunotherapy and Biomarkers Open access

  7

  citations
• Bidirectional crosstalk between epithelial–mesenchymal plasticity and IFN γ -induced PD-L1 expression promotes tumour progression

  2022 Royal Society Open Science article Medicine Cancer Cells and Metastasis Open access

  11

  citations
• CRISPR Activation Screening Identifies VGLL3–TEAD1–RUNX1/3 as a Transcriptional Complex for PD-L1 Expression

  2022 The Journal of Immunology article Medicine Cancer Immunotherapy and Biomarkers Open access

  18

  citations
• Quantifying the contribution of transcription factor activity, mutations and microRNAs to CD274 expression in cancer patients

  2022 Scientific Reports article Medicine Cancer Immunotherapy and Biomarkers Open access

  10

  citations
• Bidirectional crosstalk between epithelial-mesenchymal plasticity and IFNγ-induced PD-L1 expression promotes tumor progression

  2022 bioRxiv (Cold Spring Harbor Laboratory) preprint Medicine Cancer Cells and Metastasis Open access

  1

  citations
• Emerging Role of PD-1/PD-L1 Inhibitors in Chronic Liver Diseases

  2021 Frontiers in Pharmacology article Medicine Cancer Immunotherapy and Biomarkers Open access

  36

  citations
• IFN‐γ‐induced PD‐L1 expression on human melanocytes is impaired in vitiligo

  2021 Experimental Dermatology article Biochemistry, Genetics and Molecular Biology melanin and skin pigmentation Open access

  22

  citations
• CRISPR activation screening identifies VGLL3 and GATA2 as transcriptional regulators of PD-L1

  2021 bioRxiv (Cold Spring Harbor Laboratory) preprint Medicine Cancer Immunotherapy and Biomarkers Open access

  0

  citations
• PD-L1 and PD-L2 Expression in Cervical Cancer: Regulation and Biomarker Potential

  2020 Frontiers in Immunology article Medicine Cancer Immunotherapy and Biomarkers Open access

  114

  citations
• Genetic Screening for Novel Regulators of Immune Checkpoint Molecules

  2020 Trends in Immunology review Medicine Cancer Immunotherapy and Biomarkers

  5

  citations

18 results